SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following a massive single-day plunge sparked by a preliminary earnings warning, where the company revealed that enterprise clients are aggressively shifting budgets toward AI hardware like servers and memory at the expense of high-margin software deals. While the community is sharply divided between those calling this a generational buying opportunity based on long-term quantum computing prospects and others fearing an extinction-level event for current shareholders, traders are actively debating the broader implications of this 'Capex reprioritization' on the rest of the enterprise tech and software sector.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is generating significant community buzz due to its recent multi-billion dollar AI infrastructure deals and active global expansion, even as the stock experiences high volatility and intense debates among traders regarding its valuation and management. Investors are closely monitoring the company's ability to secure long-term hyperscaler contracts against market-wide concerns over data center supply and short-term algorithmic trading pressure.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is currently experiencing high volatility as investors weigh aggressive insider selling against strong institutional interest and the company's massive contracted revenue backlog. While market sentiment remains polarized by datacenter sector headwinds and concerns over hyperscaler compute capacity, the community is focused on critical support levels and the potential for a rebound as AI infrastructure demand continues to scale.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is seeing significant investor attention following the announcement of a multi-billion dollar, 20-year data center lease, which has sparked intense debate over the company's long-term pivot into AI infrastructure. While bulls emphasize the strategic value of the deal and its potential to diversify revenue beyond Bitcoin mining, bears remain skeptical, highlighting high debt, executive compensation concerns, and the lack of a named hyperscale tenant.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and intense social media discussion as retail investors monitor elevated short interest and tight borrow availability in hopes of a potential short squeeze. Traders are focusing on technical levels near $7 and the ongoing LivePerson merger as key catalysts that could impact the stock's momentum.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is experiencing extreme volatility as investors grapple with the recent ADR launch, the introduction of leveraged ETFs, and a broader sell-off in the KOSPI market. While some participants are capitalizing on the stock's role in the AI memory supercycle and bullish analyst coverage, others are wary of the sharp price swings and the risks posed by forced liquidations of leveraged positions.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending after reporting solid quarterly results and announcing a four-for-one stock split, though shares faced downward pressure as investors reacted to a narrower-than-expected earnings beat relative to high expectations. The community is actively debating the company's premium valuation versus its long-term potential as a leader in AI-driven cybersecurity infrastructure.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is seeing a surge in options trading activity and community buzz as investors position for a potential breakout, driven by speculation over its role as an undervalued M&A target in the cybersecurity sector. The community is actively debating its valuation relative to peers like CrowdStrike and its strategic partnerships with major tech giants, with many traders closely monitoring upcoming earnings for signs of institutional momentum.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is experiencing heightened investor interest driven by anticipation surrounding its inclusion in major Russell and S&P indices, which is expected to trigger mandatory passive institutional buying. The community remains focused on the potential for a transformative Big Pharma partnership or acquisition, as traders closely monitor clinical milestones and the company's progress toward scaling its mental health treatment pipeline.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup shares are in the spotlight following strong quarterly results that featured a revenue beat and robust trading performance, prompting institutional investors to increase their exposure to the stock. The community is actively debating the bank's long-term transformation strategy and capital return plans, viewing the recent earnings report as a validation of its ongoing operational restructuring.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akero Therapeutics, Inc. (NASDAQ:AKRO) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO - Get Free Report) have received an average rating of "Hold" from the fourteen research firms that are covering the stock, Marketbeat.com reports. One...

Promising Mid Cap Stocks To Watch Now - December 10th

ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Rigetti Computing, Akero Therapeutics, AltC Acquisition, D-Wave Quantum, and Ondas are the seven Mid Cap stocks to watch today...

Best Medical Stocks To Follow Now - December 10th

Eli Lilly and Company, Akero Therapeutics, and UnitedHealth Group are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of companies...

Akero Therapeutics' (AKRO) "Overweight" Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated an "overweight" rating on shares of Akero Therapeutics in a report on Wednesday...

Stempoint Capital LP Reduces Stock Position in Akero Therapeutics, Inc. $AKRO

Stempoint Capital LP trimmed its holdings in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 25.2% in the second quarter, according to its most recent filing with the Securities and...

Best Medical Stocks To Watch Now - December 9th

Eli Lilly and Company, Akero Therapeutics, and UnitedHealth Group are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly...

Vivo Capital LLC Buys 233,521 Shares of Akero Therapeutics, Inc. $AKRO

Vivo Capital LLC increased its position in Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 116.1% in the second quarter, according to its most recent 13F filing with the Securities and...

Akero Therapeutics, Inc. $AKRO Stock Holdings Lessened by Marshall Wace LLP

Marshall Wace LLP reduced its stake in Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 11.8% in the second quarter, according to the company in its most recent disclosure with the Securities...

JPMorgan Chase & Co. Sells 18,890 Shares of Akero Therapeutics, Inc. $AKRO

JPMorgan Chase & Co. reduced its position in Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 5.7% in the second quarter, according to the company in its most recent filing with the Securities...

Akero Therapeutics, Inc. $AKRO Position Boosted by Schroder Investment Management Group

Schroder Investment Management Group lifted its stake in Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 28.1% in the second quarter, according to its most recent disclosure with the...

Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company was founded by Jonathan Young and Timothy Rolph in January 2017 and is headquartered in South San Francisco, CA.

Akero Therapeutics Inc

Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AKROAkero Therapeutics Inc

Fundamentals

Latest AKRO News